Oral GLP-1 Agent Orforglipron Demonstrates Weight Maintenance After Injectable Therapy
Weight regain often occurs after patients stop using injectable weight loss medications. Many clinical trials show that individuals regain…
-
-
Regulatory Support for Oral Semaglutide and the Evolution of Obesity Therapeutics
The Committee for Medicinal Products for Human Use gave a positive opinion on May 22, 2026. This recommendation supports…
-
EMA Recommends Approval of Oral Wegovy, Positioning Semaglutide as Europe’s First Weight-Loss Pill
The European Medicines Agency recently recommended the approval of a daily weight loss pill. This medication uses semaglutide to…
-
Novel Oral GLP-1 Delivery System Bypasses Stomach Acid Without Fasting Requirements
A novel oral delivery system for GLP-1 receptor agonists was created by biomedical engineers. The fasting requirement associated with…
-
Novo Nordisk and Eli Lilly Present Competing Oral GLP-1 Data at European Congress on Obesity
Top drug makers recently shared new study results during a major medical meeting. These updates show a growing race…
-
Amazon Pharmacy Expands Same-Day Access to Oral Semaglutide Across Thousands of Locales
Amazon Pharmacy now offers same-day delivery and kiosk pickup for oral semaglutide. This change marks a major shift in…
-
Eli Lilly’s Oral GLP-1 Candidate Orforglipron Advances Through Phase III Trials, Targeting Obesity and Type 2 Diabetes Markets
Eli Lilly is making progress with a new pill called orforglipron. This medicine helps people manage weight and type…
-
Best Diet Hacks to Maximise Weight Loss on GLP-1 Medications
GLP-1 medications like semaglutide and tirzepatide have changed how we treat obesity. These drugs work by targeting receptors in…
-
GLP-1 Growth Drives Concentration Risk in Pharmaceutical Research
The pharmaceutical research returns have reached a multi-year high due to the surging demand for glucagon-like peptide-1 receptor agonists….
-
Novo Nordisk Retires Rybelsus Brand, Launches Oral Semaglutide Under Ozempic Name in US Market
Novo Nordisk officially discontinued the Rybelsus brand to simplify its product line. The company now markets the oral tablet…
